PBH

Prestige Consumer Healthcare Inc.

$44.97

2.98%
SectorHealthcareIndustryDrug Manufacturers - Specialty & GenericCountryUnited States

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name.

Source: Yahoo Finance
AI summary

Price & performance

1M-2.8%
3M-16.3%
YTD-27.6%
1Y-25.9%
52-week range—
Beta0.50
Full chart and returns against a benchmark

Q-Score

59/ 100

Quality against peers; 50 is the peer median.

Growth43
Risk73
Performance35
Valuation76
Profitability62
Leverage62
Sentiment46
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$1.1B-4.3%
Net income$190.3M-11.3%
Net margin17.5%-1.4 pts
Historical fundamentals

Revenue exposure

22%of revenue from outside the US
United States78%
Non Us22%
Largest customer20%
Regions, segments, customers and suppliers

Valuation

PBHIndustryP/E13.7435.25P/S1.832.74EV/EBITDA12.7016.35P/B1.102.46PEG—0.87
Dividend yield0.00%
Every valuation metric

Earnings

Feb 4next report, before the open
EPS estimate$1.07
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate